102 related articles for article (PubMed ID: 11423998)
1. Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts.
Lunghi P; Tabilio A; Pinelli S; Valmadre G; Ridolo E; Albertini R; Carlo-Stella C; Dall'Aglio PP; Pelicci PG; Bonati A
Hematol J; 2001; 2(2):70-80. PubMed ID: 11423998
[TBL] [Abstract][Full Text] [Related]
2. Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.
Bonati A; Carlo-Stella C; Lunghi P; Albertini R; Pinelli S; Migliaccio E; Sammarelli G; Savoldo B; Tabilio A; Dall'Aglio PP; Pelicci PG
Cancer Res; 2000 Feb; 60(3):728-32. PubMed ID: 10676660
[TBL] [Abstract][Full Text] [Related]
3. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
Arany I; Faisal A; Nagamine Y; Safirstein RL
J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice.
Sorenson CM; Sheibani N
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1085-90. PubMed ID: 12372784
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.
Lennartsson J; Blume-Jensen P; Hermanson M; Pontén E; Carlberg M; Rönnstrand L
Oncogene; 1999 Sep; 18(40):5546-53. PubMed ID: 10523831
[TBL] [Abstract][Full Text] [Related]
7. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
8. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
[TBL] [Abstract][Full Text] [Related]
9. Induction of uPA gene expression by the blockage of E-cadherin via Src- and Shc-dependent Erk signaling.
Kleiner S; Faisal A; Nagamine Y
FEBS J; 2007 Jan; 274(1):227-40. PubMed ID: 17222183
[TBL] [Abstract][Full Text] [Related]
10. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
Purkerson JM; Parker DC
J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
[TBL] [Abstract][Full Text] [Related]
11. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
14. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
[TBL] [Abstract][Full Text] [Related]
15. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
16. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of Shc proteins in normal CD34+ progenitor cells and leukemic cells.
Yang J; Li BR; Nayini J; Venugopal P; Tao M; Andres CB; Preisler HD
Blood; 1999 Jul; 94(1):373-4. PubMed ID: 10428548
[No Abstract] [Full Text] [Related]
18. RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase.
Knauf JA; Kuroda H; Basu S; Fagin JA
Oncogene; 2003 Jul; 22(28):4406-12. PubMed ID: 12853977
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
20. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
Pratt RL; Kinch MS
Oncogene; 2002 Oct; 21(50):7690-9. PubMed ID: 12400011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
